Randomized trial of platelet-transfusion thresholds in neonates

New England Journal of Medicine

Volumn 380, Issue 3, 2019, Pages 242-251

  Curley, Anna ^a   Stanworth, Simon J ^c   Willoughby, Karen ^d,e   Fustolo‑Gunnink, Susanna F ^j,k,m   Venkatesh, Vidheya ^o   Hudson, Cara ^e   Deary, Alison ^e   Hodge, Renate ^e   Hopkins, Valerie ^e   Santamaria, Beatriz Lopez ^g   Mora, Ana ^e   Llewelyn, Charlotte ^e   D'Amore, Angela ^f   Khan, Rizwan ^b   Onland, Wes ⁿ   Lopriore, Enrico ^l   Fijnvandraat, Karin ^j,m   New, Helen ^e,h   Clarke, Paul ⁱ   Watts, Timothy ^g  

^a NATIONAL MATERNITY HOSPITAL   (Ireland)

^b University of Limerick   (Ireland)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^g EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

ⁱ NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^j CENTRAL LABORATORY   (Netherlands)

^k Biostatistics and Bioinformatics   (Netherlands)

^l LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^m Departments of Hematology   (Netherlands)

ⁿ EMMA CHILDREN S HOSPITAL   (Netherlands)

^o Cloudnine hospital   (India)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENT; ARTICLE; BLEEDING; CLINICAL OUTCOME; CONTROLLED STUDY; FEMALE; HUMAN; INFANT MORTALITY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTICENTER STUDY; NEONATAL THROMBOCYTOPENIA; NEWBORN; OUTCOME ASSESSMENT; PLATELET COUNT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; THRESHOLD LIMIT VALUE; THROMBOCYTE TRANSFUSION; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; MORTALITY; PREMATURITY; THROMBOCYTOPENIA;

FEMALE; HEMORRHAGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PLATELET COUNT; PLATELET TRANSFUSION; THROMBOCYTOPENIA;

EID: 85058507712     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1807320     Document Type: Article

References (27)

1. Sparger KA, Assmann SF, Granger S, et al. Platelet transfusion practices among very-low-birth-weight infants. JAMA Pediatr 2016;170:687-94.
2. Ulusoy E, Tüfekçi O, Duman N, Kum-ral A, Irken G, Oren H. Thrombocytope-nia in neonates: causes and outcomes. Ann Hematol 2013;92:961-7.
3. Gunnink SF, Vlug R, Fijnvandraat K, van der Bom JG, Stanworth SJ, Lopriore E. Neonatal thrombocytopenia: etiology, management and outcome. Expert Rev Hematol 2014;7:387-95.
4. Sola-Visner M, Bercovitz RS. Neonatal platelet transfusions and future areas of research. Transfus Med Rev 2016;30:183-8.
5. Resch E, Hinkas O, Urlesberger B, Resch B. Neonatal thrombocytopenia-causes and outcomes following platelet transfusions. Eur J Pediatr 2018;177:1045-52.
6. Stanworth SJ, Clarke P, Watts T, et al. Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009;124(5):e826-e834.
7. Josephson CD, Su LL, Christensen RD, et al. Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009;123:278-85.
8. Cremer M, Sola-Visner M, Roll S, et al. Platelet transfusions in neonates: practices in the United States vary significantly from those in Austria, Germany, and Switzerland. Transfusion 2011;51:2634-41.
9. Andrew M, Vegh P, Caco C, et al. A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993;123:285-91.
10. Lieberman L, Bercovitz RS, Sholapur NS, Heddle NM, Stanworth SJ, Arnold DM. Platelet transfusions for critically ill patients with thrombocytopenia. Blood 2014;123:1146-1151, 1280.
11. New HV, Berryman J, Bolton-Maggs PHB, et al. Guidelines on transfusion for fetuses, neonates and older children. Br J Haematol 2016;175:784-828.
12. Venkatesh V, Curley A, Khan R, et al. A novel approach to standardised recording of bleeding in a high risk neonatal population. Arch Dis Child Fetal Neonatal Ed 2013;98:F260-F263.
13. Muthukumar P, Venkatesh V, Curley A, et al. Severe thrombocytopenia and patterns of bleeding in neonates: results from a prospective observational study and implications for use of platelet transfusions. Transfus Med 2012;22:338-43.
14. Curley A, Venkatesh V, Stanworth S, et al. Platelets for neonatal transfusion - study 2: a randomised controlled trial to compare two different platelet count thresholds for prophylactic platelet transfusion to preterm neonates. Neonatol 2014;106:102-6.
15. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978;187:1-7.
16. Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013;368:1771-80.
17. Kenton AB, Hegemier S, Smith EO, et al. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity. J Perinatol 2005;25:173-7.
18. Baharoglu MI, Cordonnier C, Al-Sha-hi Salman R, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 2016;387:2605-13.
19. Goel R, Ness PM, Takemoto CM, Krishnamurti L, King KE, Tobian AA. Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood 2015;125:1470-6.
20. McFadyen JD, Kaplan ZS. Platelets are not just for clots. Transfus Med Rev 2015; 29:110-9.
21. Stolla M, Refaai MA, Heal JM, et al. Platelet transfusion - the new immunology of an old therapy. Front Immunol 2015;6:28.
22. Ferrer-Marin F, Stanworth S, Josephson C, Sola-Visner M. Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion 2013;53:2813-21.
23. Bassan H. Intracranial hemorrhage in the preterm infant: understanding it, preventing it. Clin Perinatol 2009;36:737-62.
24. Poryo M, Boeckh JC, Gortner L, et al. Ante-, peri- and postnatal factors associated with intraventricular hemorrhage in very premature infants. Early Hum Dev 2018;116:1-8.
25. Christensen RD, Baer VL, Lambert DK, Ilstrup SJ, Eggert LD, Henry E. Association, among very-low-birthweight neonates, between red blood cell transfusions in the week after birth and severe intraventricular hemorrhage. Transfusion 2014;54:104-8.
26. Aghai ZH, Saslow JG, Mody K, et al. IFN-γ and IP-10 in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia. Pediatr Pulmonol 2013;48:8-13.
27. Mestan KK, Gotteiner N, Porta N, Grobman W, Su EJ, Ernst LM. Cord blood biomarkers of placental maternal vascular underperfusion predict bronchopulmonary dysplasia-associated pulmonary hypertension. J Pediatr 2017;185:33-41.